BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15859445)

  • 1. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
    Inada H; Jinno S; Kohase H; Fukayama H; Umino M
    Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected malignant hyperthermia in a 13-month-old: today's "typical" episode--a case report.
    Smith CA; Carvill KA; Eckert T
    AANA J; 1997 Jun; 65(3):247-9. PubMed ID: 9233094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
    Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
    J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant hyperthermia during a laparoscopic operation.
    Watari A; Kobori H; Yamamoto T
    J Minim Invasive Gynecol; 2011; 18(6):809-11. PubMed ID: 22024269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant hyperthermia in a liver transplant patient: a case report.
    Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
    Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant hyperthermia in the otology patient: the UCLA experience.
    Wackym PA; Blackwell KE
    Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
    Striebel HW; Lechner J; Wiegand C; Hartung E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two pediatric cases of malignant hyperthermia caused by sevoflurane].
    Kinouchi K; Okawa M; Fukumitsu K; Tachibana K; Kitamura S; Taniguchi A
    Masui; 2001 Nov; 50(11):1232-5. PubMed ID: 11758332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid intervention for an episode of malignant hyperthermia.
    Chartrand D
    Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignant hyperthermia in a young adolescent: A case report.
    Toh H; Shahani JM; Ali AJ
    Natl Med J India; 2014; 27(5):259-60. PubMed ID: 26037425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia in the absence of triggering agents.
    Setzer-Saade N
    Anesth Analg; 2010 Sep; 111(3):822; author reply 822-3. PubMed ID: 20733170
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-dose dantrolene is effective in treating hyperthermia and hypercapnia, and seems not to affect recovery of the allograft after liver transplantation: case report.
    Shih TH; Chen KH; Pao YY; Yang SC; Chen CL; Huang CJ; Wang CH; Jawan B; Cheng KW; Yang CH
    Transplant Proc; 2010 Apr; 42(3):858-60. PubMed ID: 20430190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia.
    Heggie J
    Can J Anaesth; 1999 Sep; 46(9):910. PubMed ID: 10490170
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
    Corvetto MA; Montaña R; Bravo MP; Altermatt FR
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
    [No Abstract]   [Full Text] [Related]  

  • 15. Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia.
    Rusyniak DE; Banks ML; Mills EM; Sprague JE
    Anesthesiology; 2004 Jul; 101(1):263; author reply 264. PubMed ID: 15220814
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
    Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dantrolene. Pharmacological and therapeutic aspects].
    Gerbershagen MU; Fiege M; Krause T; Agarwal K; Wappler F
    Anaesthesist; 2003 Mar; 52(3):238-45. PubMed ID: 12666006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant hyperthermia. Current aspects of dantrolene treatment of 2 cases of hyperthermia maligna incipiens].
    Hoffmann-Lundgren B; Kühn K; Hausdörfer J
    Anasth Intensivther Notfallmed; 1982 Jun; 17(3):169-70. PubMed ID: 7125160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognizing and treating malignant hyperthermia.
    Corvetto MA; Taekman JM
    Simul Healthc; 2010 Jun; 5(3):169-72. PubMed ID: 20651479
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
    Magistris F; Gamble J
    A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.